BIOLASE, Inc. announced financial results for the second quarter ended June 30, 2022, with total revenue of $12.2 million, up 34% year over year. U.S. laser sales increased 70% year over year and U.S. consumable sales increased 42% year over year.
Total revenue was $12.2 million, up 34% year over year
U.S. laser sales increased 70% year over year and U.S. consumable sales increased 42% year over year, driven by increased procedures using BIOLASE lasers
International laser sales increased 2% year over year, while international consumable sales increased 3% year over year
Waterlase Exclusive Trial Program success rate of over 55% in the second quarter
BIOLASE anticipates third quarter net revenue to exceed $10.5 million, representing growth of at least 10% year over year, and continues to expect full year net revenue to increase at least 15% from 2021 levels.